Literature DB >> 10534154

Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.

J Reynes, R Denisi, P Massip, J Izopet, I Pellegrin, M Segondy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10534154     DOI： 10.1097/00042560-199909010-00014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  2 in total

1.  Bioavailability of once- and twice-daily regimens of didanosine in human immunodeficiency virus-infected children.

Authors:  T Abreu; K Plaisance; V Rexroad; S Nogueira; R H Oliveira; L A Evangelista; R Rangel; I S Silva; C Knupp; J S Lambert
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.

Authors:  Santiago Moreno; Beatriz Hernández; Fernando Dronda
Journal:  Drugs       Date:  2007       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.